These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9292815)

  • 1. Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
    Spiera H; Asbell PA; Simpson DM
    J Rheumatol; 1997 Sep; 24(9):1842-3. PubMed ID: 9292815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrastructure of the lacrimal film and the "dry eye" syndrome].
    Hańczyc P
    Klin Oczna; 1991; 93(2-3):91-3. PubMed ID: 1870308
    [No Abstract]   [Full Text] [Related]  

  • 4. [The normal tear fluid and decreased tearing in patients with Sjögren's disease and Sjögren's syndrome. I. The protein and glucose content].
    Morozova RP; Zhaboiedov HD; Kirieiev VV; Nikolenko IA
    Ukr Biokhim Zh (1978); 1996; 68(2):77-82. PubMed ID: 9005667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
    Francis IC; Coroneo MT
    J Rheumatol; 1998 Sep; 25(9):1859. PubMed ID: 9733472
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin therapy for blepharospasm in the otolaryngology clinic.
    Lassen LF; Adams J
    ORL Head Neck Nurs; 1994; 12(3):12-3. PubMed ID: 8564763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The normal tear fluid and decreased tearing in patients with Sjögren's disease and Sjögren's syndrome. II. The lipid content].
    Morozova RP; Zhaboiedov HD; Kirieiev VV; Nikolenko IA
    Ukr Biokhim Zh (1978); 1996; 68(2):82-7. PubMed ID: 9005668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of blepharospasm with botulinum toxin type A.
    Nüssgens Z; Roggenkämper P
    Ger J Ophthalmol; 1995 Nov; 4(6):363-7. PubMed ID: 8751102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A.
    Guntinas-Lichius O
    Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439
    [No Abstract]   [Full Text] [Related]  

  • 14. Sjögren's syndrome. A dry-eyed diary.
    Tarail J
    Am J Nurs; 1987 Mar; 87(3):324-6. PubMed ID: 3644597
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin.
    Price J; O'Day J
    J Clin Neuroophthalmol; 1993 Mar; 13(1):67-71. PubMed ID: 8501266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of idiopathic blepharospasm with botulinum toxin A].
    Toczołowski J; Romaniuk W; Wróblewska E; Stelmasiak Z; Lewandowska-Furmanik M
    Klin Oczna; 1994 Mar; 96(3):95-6. PubMed ID: 8090009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beneficial effect of the local application of plasma fibronectin and autologous serum in patients with the keratoconjunctivitis sicca of Sjögren's syndrome].
    Kono I; Kono K; Narushima K; Akama T; Suzuki H; Yamane K; Kashiwagi H
    Ryumachi; 1986 Oct; 26(5):339-43. PubMed ID: 3603237
    [No Abstract]   [Full Text] [Related]  

  • 18. Sjögren's syndrome.
    Rothschild BM
    Compr Ther; 1996 Jan; 22(1):39-43. PubMed ID: 8654023
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome in the elderly].
    Gentric-Tilly A
    Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.